BridgeBio Pharma Inc BBIO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:39 PM EDT
11.50quote price arrow down-0.06 (-0.52%)
Volume
113,816
Close
11.56quote price arrow down-0.04 (-0.34%)
Volume
1,650,956
52 week range
4.98 - 53.57
Loading...
  • Open11.50
  • Day High11.95
  • Day Low11.25
  • Prev Close11.60
  • 52 Week High53.57
  • 52 Week High Date11/05/21
  • 52 Week Low4.98
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap1.714B
  • Shares Out148.25M
  • 10 Day Average Volume3.27M
  • Dividend-
  • Dividend Yield-
  • Beta0.72
  • YTD % Change-30.7

KEY STATS

  • Open11.50
  • Day High11.95
  • Day Low11.25
  • Prev Close11.60
  • 52 Week High53.57
  • 52 Week High Date11/05/21
  • 52 Week Low4.98
  • 52 Week Low Date05/12/22
  • Market Cap1.714B
  • Shares Out148.25M
  • 10 Day Average Volume3.27M
  • Dividend-
  • Dividend Yield-
  • Beta0.72
  • YTD % Change-30.7

RATIOS/PROFITABILITY

  • EPS (TTM)-3.49
  • P/E (TTM)-3.31
  • Fwd P/E (NTM)-3.27
  • EBITDA (TTM)-533.389M
  • ROE (TTM)-192.44%
  • Revenue (TTM)90.67M
  • Gross Margin (TTM)94.43%
  • Net Margin (TTM)-570.41%
  • Debt To Equity (MRQ)-165.10%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BridgeBio Pharma Inc

There is no recent news for this security.

Profile

MORE
BridgeBio Pharma, Inc. is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. The Company's pipeline of approximately 30 development programs ranges from early science to advanced clinical trials and its commercial organization is focused on delivering the Company's first two approved therapies and preparing for the...
Neil Kumar Ph.D.
President, Chief Executive Officer, Director
Brian Stephenson Ph.D.
Chief Financial Officer, Principal Accounting Officer
Address
c/o BridgeBio Pharma
Inc., 42 Kipling Street
Palo Alto, CA
94301
United States

Top Peers

SYMBOLLASTCHG%CHG
RVNC
Revance Therapeutics Inc
22.12-0.37-1.65%
KYMR
Kymera Therapeutics Inc
33.74-0.03-0.09%
LYEL
Lyell Immunopharma Inc
7.52+0.21+2.87%
ADPT
Adaptive Biotechnologies Corp
12.67+0.35+2.84%
ENTA
Enanta Pharmaceuticals Inc
70.46+2.47+3.63%